Similarly, a retrospective study conducted on patients with breast cancer demonstrated that 4E-BP1 and S6K2 were correlated with poor prognosis and endocrine resistance (Karlsson et al., 2013). This evidence concerns the gene RPS6KB2 and breast carcinoma.